FDA cautions customers about liquor based hand sanitizers bundled in containers Kumar Jeetendra | August 27, 2020 The U.S. Food and Drug Administration (FDA) is warning consumers around alcohol-based hand sanitizers which are being packaged in containers that may seem as food or beverages and might place users at risk of severe harm or death when ingested. The bureau has found that some hand sanitizers are being packaged in beer cans, children’s …
Protein-based COVID-19 vaccine trial launched by Sanofi and GSK Kumar Jeetendra | September 3, 2020 French drugmaker Sanofi and its British peer GSK have begun a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical firms race to develop treatments against the coronavirus pandemic. Sanofi and GSK said in a joint statement on Thursday they’d begun the”Stage 1/2″ trial for their adjuvanted COVID-19 vaccine, and that they expect to …
90 Percent of China’s Sinovac Workers, Households took coronavirus vaccine, says CEO Kumar Jeetendra | September 7, 2020 Approximately 90 percent of Sinovac Biotech Ltd employees and their families have obtained an experimental coronavirus vaccine developed by the Chinese company under the nation’s emergency usage programme, its chief executive said on Sunday. The extent of inoculations under the emergency programme, which China launched in July but has released few details about, points to …
China favors first nasal spray COVID-19 antibody for preliminaries Kumar Jeetendra | September 10, 2020 China has approved for trials its initial nasal spray vaccine to combat the novel coronavirus that has claimed over 904,000 lives and infected more than 27 million people globally, official media here reported on September 10. China’s only nasal spray vaccine against the coronavirus is anticipated to start phase I clinical trials in November, and …
Key China COVID-19 examination delivered results that affected ensuing exploration on Covid Kumar Jeetendra | September 18, 2020 Crucial China COVID-19 study produced results that Affected subsequent research on coronavirus Early in the start of the COVID-19 pandemic, a small study in China produced results that affected subsequent research on the virus. Researchers at the University of Cincinnati used the same research parameters on a much larger patient population and reached completely different …
Bharat Biotech set to create intranasal COVID-19 immunization: Here is everything you require to know Kumar Jeetendra | September 23, 2020 Bharat Biotech Place to Create intranasal COVID-19 vaccine: This is all you need to know Hyderabad-based Bharat Biotech announced on September 23 that it has collaborated with the Washington University School of Medicine to develop an intranasal COVID-19 vaccine. Here are seven things you need to know about the novel chimp-adenovirus vaccine candidate: Bharat Biotech …
‘Quiet’ influx of neurological results might be on its way due to COVID-19 Kumar Jeetendra | September 23, 2020 Is the world ready a tide of neurological consequences which might be on its way as a result of COVID-19? A group of neuroscientists and clinicians are examining the potential link between COVID-19 and increased risk of Parkinson’s disease, and measures to get ahead of the curve. In a review paper published today, researchers put …
Molecular investigation of COVID-19’s subsequent wave shows freak infections connected to quick spread Kumar Jeetendra | September 24, 2020 Molecular analysis of COVID-19’s powerful second wave in Houston — from May 12 to July 7 — shows that a mutated virus strain linked to higher transmission and infection rates than the coronavirus strains that caused Houston’s first wave. Gene sequencing results from 5,085 COVID-positive patients analyzed at Houston Methodist since early March show a …
New T-cell-based immunization procedure gives more extensive insurance against occasional flu Kumar Jeetendra | September 24, 2020 As Americans begin pulling their sleeves up for an annual flu vaccine, researchers at the University of Wisconsin-Madison have provided new insights into an alternate vaccine approach that provides wider protection against seasonal flu. In a study published in Cell Reports Medicine today (Sept. 22), scientists describe a T-cell-based vaccine strategy that’s effective against multiple …
New analytic instrument may permit on-the-spot recognition of Covid disease Kumar Jeetendra | September 25, 2020 Scientists at the University of Warwick have demonstrated a possible diagnostic tool for detecting Covid-19 using sugars will operate with a virus as opposed to just its proteins, a significant step in making it a viable evaluation in future. Coronavirus diagnostics currently require centralized facilities and collection/distribution of swabs and outcomes are’next day’. A new …
Yale assigns three free research facilities to perform SalivaDirect COVID-19 test Kumar Jeetendra | September 26, 2020 Laboratory evaluations of surgical and N95 masks by researchers at the University of California, Davis, show that they do cut down the amount of aerosolized particles generated during breathing, coughing and talking. Tests of homemade fabric face coverings, however, show that the fabric itself releases a large amount of fibers to the air, underscoring the …
Cat que infection: Another virus from China can possibly trigger general health emergency in India:ICMR Kumar Jeetendra | September 28, 2020 At a time when India is still grappling with the novel coronavirus pandemic that started in China’s Wuhan, scientists have warned of another virus from China that has the potential to spread diseases in India. Researchers at the Indian Council of Medical Research (ICMR) have discovered that the’cat que virus’ (CQV), that has infected many …
